IP Library › Assignment 039293/0216
Patent Assignment
Reel/Frame 039293/0216

Merger

Recorded: 2016-07-29 Pages: 13
Assignor
ESBATECH AG
Executed: 2009-09-11
Assignee
DELENEX THERAPEUTICS AG
WAGISTRASSE 21, SCHLIEREN, CH-8952, SWITZERLAND
Covered Property (1)
Nucleic Acid Encoding Antibodies Binding to the Extracellular Domain of the Receptor Tyrosine Kinase Alk
Patent: 9,512,411 →
Application: 14/571,433 →
Publication: US 2015/0203829
Related Assignments (2)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 29, 2016
From: AUF DER MAUR, ADRIAN; BARBERIS, ALCIDE; LICHTLEN, PETER
To: ESBATECH AG
Reel/Frame 039293/0167 →
Change of Name Aug 8, 2016
From: DELENEX THERAPEUTICS AG
To: CELL MEDICA SWITZERLAND AG
Reel/Frame 039629/0573 →